查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1472372

吸入膠囊市場：按類型、按應用分類：2023-2032 年全球機會分析與產業預測

Inhalation Capsules Market By Type (Gelatin Capsules, Hypromellose Capsules), By Application (Asthma Treatment, COPD Management, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 320 Pages | 商品交期: 2-3個工作天內

價格

全球吸入膠囊市場預計到 2032 年將達到 14.649 億美元，2023 年至 2032 年複合年成長率為 6.4%，而 2022 年為 8.224 億美元。

吸入膠囊市場-IMG1

吸入膠囊由於能夠將藥物直接輸送到肺部，因此可以快速且強化地治療呼吸系統疾病。這種客製化的劑量策略可以提高治療效果，同時最大限度地減少全身副作用。膠囊通常設計為與特殊吸入裝置一起使用，例如乾粉吸入器（DPI）或定量吸入器（MDI）。隨著製藥業不斷尋求新的、更有效的藥物治療方法，吸入膠囊正在成為可行的選擇。

預計推動市場成長的主要原因之一是透過吸入實現的藥物輸送的出色功效。呼吸系統提供了直接有效的循環途徑，使藥物活動能夠立即開始。這對於治療以嚴重惡化為特徵、需要立即緩解的疾病尤其重要。肺部為藥物吸收提供了巨大的表面積，薄的肺泡膜使治療化學物質能夠快速到達血液。因此，吸入膠囊比傳統口服給藥表現出更快、更直接的藥理反應，使患者能夠更快地緩解症狀並獲得更好的整體結果。快速起效提高了吸入膠囊的有效性。

監督藥品（尤其是吸入膠囊）的法律規範是預計阻礙市場收益成長的主要因素之一。監管機構使用嚴格的標準和流程來確保藥品的安全性、有效性和高品質。製造商必須遵守良好生產規範 (GMP)，並且必須完全控制製造流程的每個步驟。遵守這些法規需要在技術、設備和人員培訓方面進行大量投資，這增加了整個製造過程的複雜性。吸入膠囊的複雜設計和內容物增加了其複雜性。這些膠囊通常包含聚合物等特殊材料，並且必須滿足嚴格的穩定性、相容性和生物相容性標準。

吸入膠囊為製藥公司重新配製現有藥物或引入可透過呼吸途徑成功給藥的新化學物質提供了獨特的機會。吸入膠囊具有起效更快、全身副作用更少和患者依從性更好等優點，有可能振興藥物開發平臺。製藥業可以利用這些前景，投資研發生產用於各種治療領域的吸入製劑，包括呼吸系統疾病、全身性疾病，甚至免疫接種。所有這些因素預計將在預測期內為吸入膠囊市場創造一些成長機會。

本報告介紹的主要企業包括 Capsugel、Qualicaps、ACG Worldwide、Cipla、諾華、阿斯特捷利康 plc、Chiesi Farmaceutici SpA、Elpen SA、Vectura Group Plc 和 Boehringer Ingelheim GmbH。市場參與企業繼續透過產品系列多元化和併購等策略，努力在競爭激烈的市場中獲得優勢地位。

相關人員的主要利益

  • 該報告提供了 2022 年至 2032 年吸入膠囊市場分析的細分市場、當前趨勢、估計/趨勢和動態的定量分析，並確定了吸入膠囊市場的強大機會。
  • 我們提供市場研究以及與市場促進因素、市場限制和市場機會相關的資訊。
  • 波特的五力分析強調買家和供應商幫助相關人員做出利潤驅動的商業決策並加強供應商-買家網路的效力。
  • 吸入膠囊市場區隔的詳細分析將有助於確定市場機會。
  • 每個地區的主要國家都根據其對全球市場的收益貢獻繪製了地圖。
  • 市場參與者定位有助於基準化分析，並提供對市場參與者當前位置的清晰了解。
  • 該報告包括對區域和全球吸入膠囊市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

可以使用此報告進行客製化（需要額外費用和時間表）

  • 製造能力
  • 產品生命週期
  • 打入市場策略
  • 按產品/細分市場細分
  • 新產品開發/主要企業產品矩陣
  • 監管指引
  • 針對客戶興趣的其他公司簡介
  • 十字交叉細分市場分析—市場規模與預測
  • 公司簡介的擴充列表
  • 歷史市場資料
  • 主要參與者的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）
  • 全球/區域/國家層級參與者的市場佔有率分析
  • SWOT分析

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 平均售價
  • 市場佔有率分析
  • 品牌佔有率分析
  • 貿易資料分析
  • 產品消費
  • 價值鏈分析
  • 關鍵監管分析
  • 專利情況
  • 監管指引
  • 贖回場景

第4章吸入膠囊市場：依類型

  • 概述
  • 明膠膠囊
  • 羥丙甲纖維素膠囊

第5章吸入膠囊市場：依應用分類

  • 概述
  • 氣喘治療
  • 慢性阻塞性肺病管理
  • 其他

第6章吸入膠囊市場：依地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 伊爾泰
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第8章 公司簡介

  • Capsugel
  • Qualicaps
  • ACG Worldwide
  • Cipla
  • Novartis
  • AstraZeneca Plc
  • CHIESI Farmaceutici SpA
  • Elpen SA
  • Vectura Group plc.
  • Boehringer Ingelheim GmbH
Product Code: A296225

The global inhalation capsule market is anticipated to reach $1,464.9 million by 2032, growing from $822.4 million in 2022 at a CAGR of 6.4 % from 2023 to 2032.

Inhalation Capsules Market - IMG1

Inhalation capsules' capacity to deliver medications directly to the lungs allows for quick and concentrated treatment of respiratory illnesses. This customized administration strategy minimizes systemic side effects while boosting therapeutic efficacy. Typically, capsules are designed to be used with specialized inhalation devices such as dry powder inhalers (DPIs) or metered-dose inhalers (MDIs). As the pharmaceutical industry continues to look for new and more effective ways to provide medication, inhalation capsules are emerging as a viable option.

One of the key reasons projected to drive the market growth is the exceptional efficacy of medicine delivery achieved by inhalation. The respiratory system offers a direct and efficient route to the circulation, allowing medication activity to begin immediately. This is particularly crucial for treating diseases characterized by severe aggravations, as quick relief is required. The lungs provide a huge surface area for drug absorption, and the thin alveolar membranes allow therapeutic chemicals to reach the bloodstream rapidly. As a result, inhalation capsules give a more rapid and direct pharmacological response than traditional oral delivery, allowing patients to experience quicker relief and better overall outcomes. The rapid onset of action increases the efficacy of inhalation capsules.

Stringent regulatory framework that oversees pharmaceutical products, particularly inhalation capsules is one of the major factors anticipated to hamper the market revenue growth. Regulatory authorities use strict criteria and processes to ensure that pharmaceuticals are safe, effective, and of high quality. Manufacturers need to stick to Good Manufacturing Practices (GMP), which requires maintaining complete control over every stage of the production process. Compliance with these regulations necessitates substantial investment in technology, equipment, and personnel training, which adds to the overall complexity of the production process. The intricate design and content of inhalation capsules contribute to their complexity. These capsules usually include specialized materials, such as polymers, that must meet stringent stability, compatibility, and biocompatibility criteria.

Inhalation capsules provide pharmaceutical firms a unique chance to reformulate current medications or introduce novel chemicals that can be successfully given via the respiratory route. Inhalation capsule has the potential to revitalize drug development pipelines by providing benefits such as a faster start of action, less systemic adverse effects, and better patient compliance. The pharmaceutical sector may capitalize on these prospects by investing in R&D to produce inhalable formulations for a variety of therapeutic areas, including respiratory disorders, systemic ailments, and even vaccinations. All these factors are anticipated to create several growth opportunities in the inhalation capsules market during the forecast period.

The key players profiled in this report include Capsugel, Qualicaps, ACG Worldwide, Cipla, Novartis, AstraZeneca plc, Chiesi Farmaceutici S.p.A., Elpen S.A., Vectura Group Plc, and Boehringer Ingelheim GmbH. The market players are continuously striving to achieve a dominant position in this competitive market using strategies such as diversification of product portfolios & mergers and acquisitions.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the inhalation capsules market analysis from 2022 to 2032 to identify the prevailing inhalation capsules market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the inhalation capsules market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global inhalation capsules market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Manufacturing Capacity
  • Product Life Cycles
  • Go To Market Strategy
  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • Market share analysis of players at global/region/country level
  • SWOT Analysis

Key Market Segments

By Type

  • Gelatin Capsules
  • Hypromellose Capsules

By Application

  • Asthma Treatment
  • COPD Management
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Iltay
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Capsugel
    • Qualicaps
    • ACG Worldwide
    • Cipla
    • Novartis
    • AstraZeneca Plc
    • CHIESI Farmaceutici S.p.A.
    • Elpen S.A.
    • Vectura Group plc.
    • Boehringer Ingelheim GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. Average Selling Price
  • 3.6. Market Share Analysis
  • 3.7. Brand Share Analysis
  • 3.8. Trade Data Analysis
  • 3.9. Product Consumption
  • 3.10. Value Chain Analysis
  • 3.11. Key Regulation Analysis
  • 3.12. Patent Landscape
  • 3.13. Regulatory Guidelines
  • 3.14. Reimbursement Scenario

CHAPTER 4: INHALATION CAPSULES MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Gelatin Capsules
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Hypromellose Capsules
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: INHALATION CAPSULES MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Asthma Treatment
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. COPD Management
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: INHALATION CAPSULES MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by Type
    • 6.2.3. Market size and forecast, by Application
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Market size and forecast, by Type
      • 6.2.4.1.2. Market size and forecast, by Application
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Market size and forecast, by Type
      • 6.2.4.2.2. Market size and forecast, by Application
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Market size and forecast, by Type
      • 6.2.4.3.2. Market size and forecast, by Application
  • 6.3. Europe
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by Type
    • 6.3.3. Market size and forecast, by Application
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Market size and forecast, by Type
      • 6.3.4.1.2. Market size and forecast, by Application
      • 6.3.4.2. UK
      • 6.3.4.2.1. Market size and forecast, by Type
      • 6.3.4.2.2. Market size and forecast, by Application
      • 6.3.4.3. France
      • 6.3.4.3.1. Market size and forecast, by Type
      • 6.3.4.3.2. Market size and forecast, by Application
      • 6.3.4.4. Spain
      • 6.3.4.4.1. Market size and forecast, by Type
      • 6.3.4.4.2. Market size and forecast, by Application
      • 6.3.4.5. Iltay
      • 6.3.4.5.1. Market size and forecast, by Type
      • 6.3.4.5.2. Market size and forecast, by Application
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Market size and forecast, by Type
      • 6.3.4.6.2. Market size and forecast, by Application
  • 6.4. Asia-Pacific
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by Type
    • 6.4.3. Market size and forecast, by Application
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Market size and forecast, by Type
      • 6.4.4.1.2. Market size and forecast, by Application
      • 6.4.4.2. Japan
      • 6.4.4.2.1. Market size and forecast, by Type
      • 6.4.4.2.2. Market size and forecast, by Application
      • 6.4.4.3. India
      • 6.4.4.3.1. Market size and forecast, by Type
      • 6.4.4.3.2. Market size and forecast, by Application
      • 6.4.4.4. South Korea
      • 6.4.4.4.1. Market size and forecast, by Type
      • 6.4.4.4.2. Market size and forecast, by Application
      • 6.4.4.5. Australia
      • 6.4.4.5.1. Market size and forecast, by Type
      • 6.4.4.5.2. Market size and forecast, by Application
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Market size and forecast, by Type
      • 6.4.4.6.2. Market size and forecast, by Application
  • 6.5. LAMEA
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by Type
    • 6.5.3. Market size and forecast, by Application
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Market size and forecast, by Type
      • 6.5.4.1.2. Market size and forecast, by Application
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Market size and forecast, by Type
      • 6.5.4.2.2. Market size and forecast, by Application
      • 6.5.4.3. United Arab Emirates
      • 6.5.4.3.1. Market size and forecast, by Type
      • 6.5.4.3.2. Market size and forecast, by Application
      • 6.5.4.4. South Africa
      • 6.5.4.4.1. Market size and forecast, by Type
      • 6.5.4.4.2. Market size and forecast, by Application
      • 6.5.4.5. Rest of LAMEA
      • 6.5.4.5.1. Market size and forecast, by Type
      • 6.5.4.5.2. Market size and forecast, by Application

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product mapping of top 10 player
  • 7.4. Competitive dashboard
  • 7.5. Competitive heatmap
  • 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

  • 8.1. Capsugel
    • 8.1.1. Company overview
    • 8.1.2. Key executives
    • 8.1.3. Company snapshot
  • 8.2. Qualicaps
    • 8.2.1. Company overview
    • 8.2.2. Key executives
    • 8.2.3. Company snapshot
  • 8.3. ACG Worldwide
    • 8.3.1. Company overview
    • 8.3.2. Key executives
    • 8.3.3. Company snapshot
  • 8.4. Cipla
    • 8.4.1. Company overview
    • 8.4.2. Key executives
    • 8.4.3. Company snapshot
  • 8.5. Novartis
    • 8.5.1. Company overview
    • 8.5.2. Key executives
    • 8.5.3. Company snapshot
  • 8.6. AstraZeneca Plc
    • 8.6.1. Company overview
    • 8.6.2. Key executives
    • 8.6.3. Company snapshot
  • 8.7. CHIESI Farmaceutici S.p.A.
    • 8.7.1. Company overview
    • 8.7.2. Key executives
    • 8.7.3. Company snapshot
  • 8.8. Elpen S.A.
    • 8.8.1. Company overview
    • 8.8.2. Key executives
    • 8.8.3. Company snapshot
  • 8.9. Vectura Group plc.
    • 8.9.1. Company overview
    • 8.9.2. Key executives
    • 8.9.3. Company snapshot
  • 8.10. Boehringer Ingelheim GmbH
    • 8.10.1. Company overview
    • 8.10.2. Key executives
    • 8.10.3. Company snapshot

LIST OF TABLES

  • TABLE 01. GLOBAL INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. INHALATION CAPSULES MARKET FOR GELATIN CAPSULES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. INHALATION CAPSULES MARKET FOR HYPROMELLOSE CAPSULES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 05. INHALATION CAPSULES MARKET FOR ASTHMA TREATMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. INHALATION CAPSULES MARKET FOR COPD MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. INHALATION CAPSULES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. INHALATION CAPSULES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. NORTH AMERICA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 10. NORTH AMERICA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA INHALATION CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 12. U.S. INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 13. U.S. INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 14. CANADA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 15. CANADA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 16. MEXICO INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 17. MEXICO INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 18. EUROPE INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 19. EUROPE INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE INHALATION CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 21. GERMANY INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 22. GERMANY INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. UK INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 24. UK INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. FRANCE INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. FRANCE INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. SPAIN INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. SPAIN INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. ILTAY INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 30. ILTAY INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 31. REST OF EUROPE INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. REST OF EUROPE INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. ASIA-PACIFIC INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. ASIA-PACIFIC INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. ASIA-PACIFIC INHALATION CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 36. CHINA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. CHINA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. JAPAN INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 39. JAPAN INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. INDIA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 41. INDIA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. SOUTH KOREA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 43. SOUTH KOREA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. AUSTRALIA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 45. AUSTRALIA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. REST OF ASIA-PACIFIC INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 47. REST OF ASIA-PACIFIC INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. LAMEA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 49. LAMEA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. LAMEA INHALATION CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 51. BRAZIL INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 52. BRAZIL INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 53. SAUDI ARABIA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 54. SAUDI ARABIA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. UNITED ARAB EMIRATES INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 56. UNITED ARAB EMIRATES INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. SOUTH AFRICA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. SOUTH AFRICA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 59. REST OF LAMEA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. REST OF LAMEA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. CAPSUGEL: KEY EXECUTIVES
  • TABLE 62. CAPSUGEL: COMPANY SNAPSHOT
  • TABLE 63. QUALICAPS: KEY EXECUTIVES
  • TABLE 64. QUALICAPS: COMPANY SNAPSHOT
  • TABLE 65. ACG WORLDWIDE: KEY EXECUTIVES
  • TABLE 66. ACG WORLDWIDE: COMPANY SNAPSHOT
  • TABLE 67. CIPLA: KEY EXECUTIVES
  • TABLE 68. CIPLA: COMPANY SNAPSHOT
  • TABLE 69. NOVARTIS: KEY EXECUTIVES
  • TABLE 70. NOVARTIS: COMPANY SNAPSHOT
  • TABLE 71. ASTRAZENECA PLC: KEY EXECUTIVES
  • TABLE 72. ASTRAZENECA PLC: COMPANY SNAPSHOT
  • TABLE 73. CHIESI FARMACEUTICI S.P.A.: KEY EXECUTIVES
  • TABLE 74. CHIESI FARMACEUTICI S.P.A.: COMPANY SNAPSHOT
  • TABLE 75. ELPEN S.A.: KEY EXECUTIVES
  • TABLE 76. ELPEN S.A.: COMPANY SNAPSHOT
  • TABLE 77. VECTURA GROUP PLC.: KEY EXECUTIVES
  • TABLE 78. VECTURA GROUP PLC.: COMPANY SNAPSHOT
  • TABLE 79. BOEHRINGER INGELHEIM GMBH: KEY EXECUTIVES
  • TABLE 80. BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT

LIST OF FIGURES

  • FIGURE 01. INHALATION CAPSULES MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF INHALATION CAPSULES MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN INHALATION CAPSULES MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN INHALATION CAPSULES MARKET (2023-2032)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL INHALATION CAPSULES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. IMPACT OF KEY REGULATION: INHALATION CAPSULES MARKET
  • FIGURE 12. PATENT ANALYSIS BY COMPANY
  • FIGURE 13. PATENT ANALYSIS BY COUNTRY
  • FIGURE 14. INHALATION CAPSULES MARKET, BY TYPE, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF INHALATION CAPSULES MARKET FOR GELATIN CAPSULES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF INHALATION CAPSULES MARKET FOR HYPROMELLOSE CAPSULES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. INHALATION CAPSULES MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF INHALATION CAPSULES MARKET FOR ASTHMA TREATMENT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF INHALATION CAPSULES MARKET FOR COPD MANAGEMENT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF INHALATION CAPSULES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. INHALATION CAPSULES MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 22. U.S. INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 23. CANADA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 24. MEXICO INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. GERMANY INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. UK INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. FRANCE INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. SPAIN INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. ILTAY INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. REST OF EUROPE INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. CHINA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. JAPAN INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. INDIA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. SOUTH KOREA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. AUSTRALIA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. REST OF ASIA-PACIFIC INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. BRAZIL INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SAUDI ARABIA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. UNITED ARAB EMIRATES INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. SOUTH AFRICA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. REST OF LAMEA INHALATION CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 43. COMPETITIVE DASHBOARD
  • FIGURE 44. COMPETITIVE HEATMAP: INHALATION CAPSULES MARKET
  • FIGURE 45. TOP PLAYER POSITIONING, 2022